Efficacy and Safety of Azelastine +Mometasone , Nasal Spray, 140 mcg + 50 mcg, (Sandoz d.d., Slovenia) and Momat Rino Advance, Nasal Spray, 140 mcg + 50 mcg, (Glenmark, India) Administered as a Monotherapy to Patients With Seasonal Allergic Rhinitis.

Condition:   Seasonal Allergic Rhinitis Interventions:   Combination Product: Azelastine + Mometazone, nasal spray;   Combination Product: Momat Rhino Advance Sponsor:   Sandoz Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials